Q3 2022 Ascendis Pharma A/S Earnings Call Transcript
Good day, and thank you for standing by. Welcome to the Ascendis Pharma Third Quarter Earnings Conference Call. (Operator Instruction] Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Tim Lee, Senior Director, Investor Relations. Please go ahead.
/-
Thank you, operator, and thank you, everyone, for joining our third quarter 2022 financial results conference call. I'm Tim Lee, Senior Director of Investor Relations at Ascendis Pharma.
Joining me on the call today is Jan Mikkelsen, President and Chief Executive Officer; Scott Smith, Senior Vice President and Chief Financial Officer; Dr. Stina Singel, Head of Clinical Development, Oncology; Dr. Birgitte Volck, Senior Vice President, Head of Clinical Development and Medical Affairs, Endocrinology Rare Diseases; and Joe Kelly, Head of U.S. Commercial Endocrinology.
Before we begin, I would like to remind you that this
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
